Amplification and overexpression of the ERBB2 (HER-2/neu) oncogene has been implicated
as contributing to the development of human breast cancer, and as a predictor of poor�…

Electrical characteristics of living tissues have been investigated for a long time in the search
for further methods to complement the traditional investigations of pathology and physiology�…

Background. Leiomyosarcoma of soft tissue is a rare tumor. There are different opinions
regarding epidemiology and prognosis. Methods. Epidemiology and prognosis were�…

Measures of the proliferative activity of tumor cells have prognostic value in patients with
node-negative breast cancer. We studied 367 women in southern Sweden who had�…

Cancer genome sequencing has shed light on the underlying genetic aberrations that drive
tumorigenesis. However, current sequencing-based strategies, which focus on a single�…

Chromosomal copy number aberrations (CNAs) are common in breast cancer and involve
genomic regions in a frequency and combination, suggesting distinct routes of tumor�…

Background Immunohistochemical staining for mismatch repair proteins is efficient and
widely used to identify mismatch repair defective tumors. The tumors typically show uniform�…

The ERBB2 proto-oncogene was studied in 539 invasive primary breast tumors and was
found amplified (2-greater than 30 copies) in 19%. Amplification was correlated to most�…

Abstract The Tn antigen (GalNAc α-O-Ser/Thr) is heterogeneously synthesized by a variety
of tumors and contains an epitope defined by lectins and antibodies as a cluster of αGalNAc�…

Various new prognostic indicators have been identified for mammary carcinomas, but the
issue of their significance remains unsettled. The prognostic impact of p53, c‐erbB‐2, and�…